Professor
Cardiology
Dr. Allan S. Jaffe, MD
|
|
Give Review
Allan Jaffe works in the field of Cardiology. He went to medical school at University of Maryland School of Medicine. University of Maryland School of Medicine has a rank of 37 in research and a 52 in primary care He received 2 awards: "America's Top Doctors" and "Fellow (FACC)". Allan Jaffe is also a published physician. He has 99 paper published. The most recent paper is: Cardiac troponin T in patients with cardiac implantable electronic devices undergoing magnetic resonance imaging.
Publications
- Cardiac troponin T in patients with cardiac implantable electronic devices undergoing magnetic resonance imaging.
- Soluble ST2-Analytical Considerations.
- Better Ways to Move Ahead.
- 'Paradox' of troponin elevations after non-cardiac surgery.
- Soluble suppression of tumorigenicity 2 (sST2), but not Galactin-3, adds to prognostication in patients with systemic AL amyloidosis independent of NT-proBNP and Tropo...
- Comparison of conventional and high-sensitivity troponin in patients with chest pain: A collaborative meta-analysis.
- Platelet function testing in Acute cardiac care - is there a role for prediction or prevention of stent thrombosis and bleeding?
- Improving the 510(k) FDA Process for Cardiac Troponin Assays: In Search of Common Ground.
- Fundamental Concepts of Effective Troponin Use- Important Principles For Internists.
- Republished: Clinical implications of the Third Universal Definition of Myocardial Infarction.
- Early Trends in N-Terminal Pro-Brain Natriuretic Peptide Values After Left Ventricular Assist Device Implantation for Chronic Heart Failure.
- Men are different than women: It's true for cardiac troponin too.
- Emerging biomarkers for acute Heart conditions.
- B-type Natriuretic Peptide clinical activation in Aortic Stenosis: Impact on Long-Term Survival.
- High sensitivity cardiac troponin T in patients with immunoglobulin light chain amyloidosis.
- Letter in response to "Use of preoperative cardiac troponin T to identify patients at risk for Acute myocardial infraction and long-term mortality after major noncardi...
- Clinical differences between total PAPP-A and measurements specific for the products of free PAPP-A activity in patients with stable cardiovascular Disease.
- In memoriam: burton e. Sobel a tribute from family, friends and colleagues october 21, 1937 - may 3, 2013.
- Fatty acids and TxA2 generation, in the absence of platelet-COX-1 activity.
- Thromboxane A2 Generation, in the Absence of Platelet COX-1 Activity, in Patients With and Without Atherothrombotic Myocardial Infarction.
- High-sensitivity cardiac troponin T in prediction and diagnosis of Myocardial infarction and long-term mortality after noncardiac surgery.
- Defining high-sensitivity cardiac troponin concentrations in the community.
- Biological variation of galectin-3 and soluble ST2 for chronic Heart failure: Implication on interpretation of test results.
- Erdheim-Chester Disease with cardiac involvement successfully treated with anakinra.
- Another Piece to the Troponin Puzzle: Better Confirmed, and with a Path Forward.
- "Copeptin Helps "Copeptin Helps in the Early Detection Of Patients with Acute Myocardial Infarction": the primary results of the CHOPIN Trial.
- Are Biomarkers the Answer to the Heart Failure Readmissions Problem?
- A Non-classical Presentation of Tangier Disease with Three ABCA1 Mutations.
- Cardiac troponin T before and after Kidney transplantation: determinants and implications for posttransplant survival.
- Third universal definition of Myocardial infarction.
- Association of Hyponatremia and Elevated Copeptin With Death and Need for Transplantation in Ambulatory Patients With Chronic Heart Failure.
- Peri-operative Myocardial infarction and high sensitive cardiac troponin: A start but by no means a finish.
- BD rapid serum tubes reduce false positive plasma troponin T results on the Roche Cobas e411 analyzer.
- Evaluation of patients with possible cardiac chest pain: a way out of the jungle.
- Balloon Aortic Valvuloplasty under Temporary Mechanical Circulatory Support as a Bridge to Aortic Valve Replacement in a Patient with Hemodynamic Failure Secondary to ...
- Comparison of novel pro-BNP(1-108) and standard BNP assays in Heart failure patients.
- Biomarkers of vulnerable plaque: Can better ways to quantitate Pregnancy-Associated Plasma Protein A (PAPP-A) help?
- Why all the struggle about CK-MB and PCI?
- Interpreting changes in troponin--clinical judgment is essential.
- Serial measurements of midregion proANP and copeptin in ambulatory patients with Heart failure: incremental prognostic value of novel biomarkers in Heart failure.
- Troponin Release--Reversible or Irreversible Injury? Should We Care?
- Decision support tool for early differential diagnosis of Acute lung injury and cardiogenic pulmonary edema in medical critically ill patients.
- Diseased skeletal muscle a noncardiac source of increased circulating concentrations of cardiac troponin T.
- High-Sensitivity Cardiac Troponin Assays--Change Is Important.
- Rapid exclusion of Acute myocardial infarction in patients with undetectable troponin using a high-sensitivity assay.
- Diastolic dysfunction and mortality in severe sepsis and septic shock.
- Development of a Clinical Prediction Rule for 30-Day Cardiac Events in Emergency Department Patients With Chest Pain and Possible Acute Coronary Syndrome.
- Multiplex protein assay performance/evaluation and the requirement for precision and correlation to clinical assays.
- Assessment of clinical performance without adequate analytical validation: A prescription for confusion.
- Troponin T levels and infarct size by SPECT Myocardial perfusion imaging.
- Biologic Variation of a Novel Cardiac Troponin I Assay.
- Troponin elevations after electroconvulsive therapy: the need for caution.
- Comparison of Mass Spectrometry and Clinical Assay Measurements of Circulating Fragments of B-Type Natriuretic Peptide in Patients with Chronic Heart Failure.
- Recommendations for the use of natriuretic peptides in Acute cardiac care: A position statement from the Study Group on Biomarkers in Cardiology of the ESC Working Gro...
- Serum caspase-3 p17 fragment is elevated in patients with ST-segment elevation Myocardial infarction: a novel observation.
- Myocarditis with ST Elevation and Elevated Cardiac Enzymes Misdiagnosed as an ST-elevation Myocardial Infarction.
- Increasing cardiac troponin changes measured by a research high-sensitivity troponin I assay: absolute vs percentage changes and long-term outcomes in a chest pain coh...
- Significance of elevated cardiac troponin T levels in critically ill patients with Acute respiratory disease.
- Relation of ADRB1, CYP2D6, and UGT1A1 polymorphisms with dose of, and response to, carvedilol or metoprolol therapy in patients with chronic Heart failure.
- Biological and analytical variability of a novel high-sensitivity cardiac troponin T assay.
- Being rational about (im)precision: a statement from the Biochemistry Subcommittee of the Joint European Society of Cardiology/American College of Cardiology Foundatio...
- WITHDRAWN: Corrigendum to "High-sensitive cardiac troponin I (hs-cTnl) values in patients with stable cardiovascular Disease: An initial foray" [Clinica Chim...
- Identification of Myocardial injury in the emergency setting.
- Left ventricular function and C-reactive protein levels in Acute myocardial infarction.
- High-sensitivity cardiac troponin: hype, help, and reality.
- 2007 universal Myocardial infarction definition change criteria for risk stratification by use of a high-sensitivity cardiac troponin I assay.
- The use of a cytokine panel to define the long-term risk stratification of Heart failure/death in patients presenting with chest pain to the emergency department.
- Trends in incidence, severity, and outcome of hospitalized Myocardial infarction.
- Analytical validation of a high-sensitivity cardiac troponin T assay.
- Peripheral blood monocyte subset assessment in non-ST-segment elevation Myocardial infarction is required.
- Sensitive cardiac troponin assays.
- Relation of cardiac troponin I measurements at 24 and 48 hours to magnetic resonance-determined infarct size in patients with ST-elevation Myocardial infarction.
- Response of novel biomarkers to BNP infusion in patients with decompensated Heart failure: a multimarker paradigm.
- Ethical issues in cardiovascular research involving humans.
- Profiles of serial changes in cardiac troponin T concentrations and outcome in ambulatory patients with chronic Heart failure.
- Short- and long-term risk stratification using a next-generation, high-sensitivity research cardiac troponin I (hs-cTnI) assay in an emergency department chest pain po...
- Pediatric brain natriuretic peptide concentrations vary with age and sex and appear to be modulated by testosterone.
- Catecholamine interference in enzymatic creatinine assays.
- PAPP-A as a marker of increased long-term risk in patients with chest pain.
- Perioperative Myocardial infarction.
- Intracardiac Thrombosis and anticoagulation therapy in cardiac amyloidosis.
- Depression screening in patients with Heart disease.
- Aborted Myocardial infarction: is it real in the troponin era?
- History of depression and survival after Acute myocardial infarction.
- Analytic and clinical utility of a next-generation, highly sensitive cardiac troponin I assay for early detection of Myocardial injury.
- Only large reductions in concentrations of natriuretic peptides (BNP and NT-proBNP) are associated with improved outcome in ambulatory patients with chronic Heart fail...
- Specificity of a high-sensitivity cardiac troponin I assay using single-molecule-counting technology.
- Long-term prognostic significance of elevated cardiac troponin levels in critically ill patients with Acute gastrointestinal bleeding.
- Value of cardiac troponin I cutoff concentrations below the 99th percentile for clinical decision-making.
- Dimensions of social support and depression in patients at increased psychosocial risk recovering from Myocardial infarction.
- The spin stops here: inhibition of lipoprotein-associated phospholipase A2-- a promising target but a negative initial trial?
- Refining our criteria: a critical challenge.
- Requiem for a heavyweight: the demise of creatine kinase-MB.
- Survival of patients on the Kidney transplant wait list: relationship to cardiac troponin T.
- Left ventricular function and Heart failure in myocardial infarction: impact of the new definition in the community.
- Diagnostic application of the universal definition of Myocardial infarction in the intensive care unit.
- Nighttime Heart rate and survival in depressed patients post acute myocardial infarction.
- Key issues in the developing synergism between cardiovascular imaging and biomarkers.
Schools
University Of Maryland School Of Medicine
Barnes Jewish Hospital S Campus
Procedures Preformed
- Ablation for Treatment of Cardiac Arrhythmias
- Cardiac Catheterization (incl. Coronary Angiography)
- Cardiac Imaging
- Cardioverter-Defibrillator or Pacemaker Insertion, Removal or Repair
- View All
Conditions Treated
- Aneurysm and Dissection of Heart
- Angina and Acute Coronary Syndrome
- Aortic Aneurysm
- Aortic Dissection
- View All
Doctors Specialties
- Cardiology
Accepted Insurances
- Choice Plus POS II
- American Enterprise Group
- American Republic
- Anthem Blue Cross Blue Shield HMO
- Anthem Blue Cross Blue Shield PPO
- Blue Preferred Plus POS
- Assurant Health
- Bakery & Confectionary Union Plan
- Blue Card PPO
- Blue Cross Blue Shield of Illinois PPO
- Blue Cross Accord
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Commercial Insurance Company
- CoreSource
- Emblem Health
- GEHA
- HealthPartners
- HealthSmart
- Choice Care PPO
- Medica
- Medicaid
- Medicare MCR
- Medico
- Meritain Health
- MultiPlan PPO
- PHCS Network PPO
- National Elevator
- Old Surety Life Insurance CompanyMedicare MCR
- Pekin Insurance
- Priority Health
- Simplifi
- Thrivent Financial
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
- Wisconsin Physicians Service
Awards
- America's Top Doctors
- Fellow (FACC)
Education
-
Washington University - Barnes-Jewish Hospital -
University of Maryland School of Medicine
Hospital
-
Mayo Clinic - Rochester, Minnesota
Drug Facts
| NPI NUMBER | 1538146626 | |
| NPPES Provider LastName | JAFFE | |
| NPPES Provider FirstName | ALLAN | |
| NPPES Provider ZIPCode | 559050001 | |
| NPPES Provider State | MN | |
| Specialty Description | Cardiology | |
| Total Claim Count | 24.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1538146626 |
| Last Name Of The Provider | JAFFE |
| First Name Of The Provider | ALLAN |
| View All |
Similar Doctors
|
|
Dr. Gerald T. Gau, MD |
|
|
Dr. Peter A. Brady, MD |
|
|
Dr. John J. Baga, MD |
|
|
Dr. Manpreet Kanwar, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Umer Saleem, MD |
|
|
Dr. Lakshminarayanan K. Venkatachalam, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Titus C. Evans, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael D. McGoon, MD |
|
|
Dr. Michael J. Osborn, MD |